【摘 要】 目的：分析肺结核伴咯血者以酚妥拉明、垂体后叶素配合治疗的有效性。方法：以2017.5～2018.3期间100例肺结核伴咯血为研究对象，所有患者均给予常规治疗，同时按治疗小组不同分组，对照组共48例(采用垂体后叶素)、观察组52例(酚妥拉明+垂体后叶素)，观察不同用药临床疗效差异，比较两组止血时间、咯血量，统计治疗期间用药所致不良反应。结果：观察组治疗率为94.2%高于对照组85.4%，P<0.05;两组止血情况，观察组止血用时短于对照组，咯血量少于对照组，P<0.05;两组不良反应情况比较，观察组发生率为11.5%低于对照组25.0%，P<0.05。结论：肺结核咯血者以酚妥拉明、垂体后叶素配合治疗，临床疗效理想，患者咯血症状改善快、咯血量少，且用药不良反应少，可推广应用。

    【关键词】 咯血;垂体后叶素;疗效;肺结核;酚妥拉明

    【中图分类号】R821.4+2

    【文献标志码】A

    【文章编号】 1005-0019(2019)14-001-01

    Abstract Objective： To analyze the effectiveness of phentolamine plus pituitrin in pulmonary tuberculosis patients with hemoptysis. Methods： 100 pulmonary tuberculosis patients with hemoptysis treated from May 2017 to March 2018 in our hospital were selected and assigned to control group(n=48) and observation group(n=52) according to different therapies. The control group was treated with pituitrin; the observation group was treated with phentolamine plus pituitrin. The clinical efficacy ......